Wedgewood Village Pharmacy, LLC FDA Inspection Record

FEI 3001779702 · Inspections, Form 483s, warning letters and import refusals

Wedgewood Village Pharmacy, LLC is an FDA-inspected facility (FEI 3001779702) located in Swedesboro, NJ, US. RegDataLab tracks 3 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Mar 24, 2022: Voluntary Action Indicated (VAI)
Inspections on record
3 (1 OAI, 2 VAI)
Last OAI inspection
Feb 11, 2013
Warning letters
1 listed by FDA for this FEI, latest Feb 21, 2014
Form 483 and inspection documents
6 in FDA's reading room
Recalls as the recalling firm
6, latest Dec 15, 2022

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 24, 2022Voluntary Action Indicated (VAI)Vermin, adjacent area (FDCA 501(a)(2)(A))
Non-microbial contamination, production area (FDCA 501(a)(2)(A))
Exposure of personnel in aspectic processing (FDCA 501(a)(2)(A))
Disruption of airflow from personnel movement (FDCA 501(a)(2)(A))
and 2 more
Sep 29, 2015Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Clothing appropriate for duties performed (21 CFR 211.28(a))
Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Environmental Monitoring System (21 CFR 211.42(c)(10)(iv))
and 2 more
Feb 11, 2013Official Action Indicated (OAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Dec 15, 2022Class IIV-0042-2023Omeprazole/Aluminum Hydroxide/Magnesium Hydroxide 2gm/4gm/4gm/30ml Banana/Marshmallow Oral… and 3 more products
Subpotent drug: Omeprazole concentration being lower than the labeled amount of 2 gm/30 mL
Jul 5, 2022Class IIV-0160-2022Prednisone in PLO 50mg/ml Transdermal Gel 1ml Prednisone 10mg/ml Oral Suspension 15ml… and 56 more products
Insanitary conditions.
Jun 10, 2022Class IID-1181-2022Bethanechol Chloride 1mg/ml, 80 ml Suspension bottles Banana/Strawberry, Qty:1, Wedgewood… and 5 more products
Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
Sep 2, 2016Class IIV-0014-2017Wedgewood Pharmacy Cyclosporine 0.2% in Corn Oil Ophthalmic Solution 15 ml Drop-Tainers…
Cyclosproine in Corn Oil 0.2% opthalmic solution is being recalled since one sterility sample did not meet specifications for…
Jun 28, 2013Class IIV-312-2013Pentosan Polysulfate Sodium (K9) 150 mg/ml aqueous solution for injection, for Veterinary…
Routine endotoxin testing of this batch indicated that the finished injection solution contained a concentration of endotoxins exceeding…
Mar 21, 2013Class IIV-221-20131) Digoxin LS (0.05 mg/mL) Liver 50 mcg/mL Elixir, Oral for Veterinary Use Only Various… and 3 more products
Digoxin for veterinary patients is being recalled since potency of medication is less than labeled amount for compounding/compounded…

Form 483s and inspection documents

  • Warning Letter Response on FDA.gov
    FDA listing date Oct 17, 2022, which is not always the inspection or issue date. Published by FDA Aug 23, 2023.
  • 483 on FDA.gov
    Inspection Mar 14, 2022 to Mar 24, 2022 (dates printed on the document). FDA listing date Mar 24, 2022. Published by FDA Sep 27, 2022.
  • 483 Response on FDA.gov
    FDA listing date Dec 9, 2015, which is not always the inspection or issue date. Published by FDA Jan 18, 2024.
  • 483 on FDA.gov
    Inspection Aug 26, 2015 to Sep 29, 2015, issued Sep 30, 2015 (dates printed on the document). FDA listing date Dec 9, 2015. Published by FDA Jan 18, 2024.
  • 483 on FDA.gov
    Inspection Aug 26, 2015 to Sep 29, 2015, issued Sep 29, 2015 (dates printed on the document). FDA listing date Dec 9, 2015. Published by FDA Jan 18, 2024.
  • 483 on FDA.gov
    Inspection on Feb 11, 2013, issued Feb 11, 2013 (dates printed on the document). FDA listing date Jul 10, 2015. Published by FDA Jan 18, 2024.

FDA record score

11 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

10 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIMar 24, 20226 x 0.63.6
Class II recall V-0042-2023, this FEI as the recalling firmDec 15, 20224 x 0.62.4
Class II recall V-0160-2022, this FEI as the recalling firmJul 5, 20224 x 0.62.4
Class II recall D-1181-2022, this FEI as the recalling firmJun 10, 20224 x 0.62.4
Class II recall V-0014-2017, this FEI as the recalling firmSep 2, 201610 years or older, so it adds no points0
Inspection classified VAISep 29, 201510 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsFeb 21, 201410 years or older, so it adds no points0
Class II recall V-312-2013, this FEI as the recalling firmJun 28, 201310 years or older, so it adds no points0
Class II recall V-221-2013, this FEI as the recalling firmMar 21, 201310 years or older, so it adds no points0
Inspection classified OAIFeb 11, 201310 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Wedgewood Village Pharmacy, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Wedgewood Village Pharmacy, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Wedgewood Village Pharmacy, LLC
Location
Swedesboro, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.